Javascript must be enabled to continue!
Lymphedema As The Initial Symptom of Lymphoma
View through CrossRef
Abstract
Background: To investigate the clinical features of lymphoma with lymphedema as the initial manifestation.Methods: We performed a retrospective study of 4676 patients with lymphedema treated at the Department of Lymphatic Surgery, Beijing Shijitan Hospital, Capital Medical University, from May 22, 2007, to December 31, 2018. Clinical manifestations and a series of conventional analyses (laboratory tests, ultrasonography, magnetic resonance imaging, computed tomography, and radionuclide imaging) were used to study these cases. Bone marrow aspiration and biopsy tests were used to support the diagnosis of lymphoma. Eleven patients of lymphoma with lymphedema as the first symptom were selected, and their clinicopathological features were analyzed retrospectively.Results: A total of 11 cases of lymphedema caused or aggravated by lymphoma were found, including 1 case of upper extremity edema, 9 cases of lower extremity edema and 1 case of systemic edema. These patients often accompanied by clinical symptoms such as feeble, emaciation, pain, mass, lymph node enlargement and so on. The proportion of patients with abnormal tumor markers was 66.7% (4/6), the prevalence of anemia among patients with malignant lymphedema was 45.5% (5/11), and the positive rates of ultrasonography, CT and MRI were 100.0% (7/7), 100.0% (8/8) and 100.0% (2/2), respectively. Eleven cases with lymphoma were confirmed by pathological diagnosis. To analyze the clinicopathological features, the main points of diagnosis were summarized.Conclusions: Lymphoma with lymphedema as the first symptom is extremely rare. It has a hidden onset. To avoid delays in the diagnosis and therapy of lymphoma, physicians should actively look for signs or symptoms of lymphedema during the follow-up period and promptly manage patients developing problems.
Title: Lymphedema As The Initial Symptom of Lymphoma
Description:
Abstract
Background: To investigate the clinical features of lymphoma with lymphedema as the initial manifestation.
Methods: We performed a retrospective study of 4676 patients with lymphedema treated at the Department of Lymphatic Surgery, Beijing Shijitan Hospital, Capital Medical University, from May 22, 2007, to December 31, 2018.
Clinical manifestations and a series of conventional analyses (laboratory tests, ultrasonography, magnetic resonance imaging, computed tomography, and radionuclide imaging) were used to study these cases.
Bone marrow aspiration and biopsy tests were used to support the diagnosis of lymphoma.
Eleven patients of lymphoma with lymphedema as the first symptom were selected, and their clinicopathological features were analyzed retrospectively.
Results: A total of 11 cases of lymphedema caused or aggravated by lymphoma were found, including 1 case of upper extremity edema, 9 cases of lower extremity edema and 1 case of systemic edema.
These patients often accompanied by clinical symptoms such as feeble, emaciation, pain, mass, lymph node enlargement and so on.
The proportion of patients with abnormal tumor markers was 66.
7% (4/6), the prevalence of anemia among patients with malignant lymphedema was 45.
5% (5/11), and the positive rates of ultrasonography, CT and MRI were 100.
0% (7/7), 100.
0% (8/8) and 100.
0% (2/2), respectively.
Eleven cases with lymphoma were confirmed by pathological diagnosis.
To analyze the clinicopathological features, the main points of diagnosis were summarized.
Conclusions: Lymphoma with lymphedema as the first symptom is extremely rare.
It has a hidden onset.
To avoid delays in the diagnosis and therapy of lymphoma, physicians should actively look for signs or symptoms of lymphedema during the follow-up period and promptly manage patients developing problems.
Related Results
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Epidemiological data on lower limb lymphedema
Epidemiological data on lower limb lymphedema
Objective: The aim of the present study was to evaluate epidemiological data of patients seen at a clinic specialized in the treatment of lymphedema. Methods: A retrospective, cro...
Anti-CTLA4 treatment reduces lymphedema risk through a systemic expansion of the FOXP3+ Treg population
Anti-CTLA4 treatment reduces lymphedema risk through a systemic expansion of the FOXP3+ Treg population
Abstract
Secondary lymphedema is a common sequel of oncologic surgery following lymphatic injury and presents a substantial global health burden for which no pharmacologica...
Lympedema Therapies
Lympedema Therapies
Secondary lymphedema refers to a condition in which the affected extremity develops progressive hypertrophy due to lymphatic fluid retention. Worldwide, secondary lymphedema is mos...
Non-invasive detection of lymphoma with circulating tumor DNA features and plasma protein marker.
Non-invasive detection of lymphoma with circulating tumor DNA features and plasma protein marker.
e19574 Background: Lymphoma is common cancer worldwide, a large group of lymphoid hematopoietic malignancies including Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) two maj...
Endoscopic and Histopathological Characteristics of Gastrointestinal Lymphoma: A Multicentric Study
Endoscopic and Histopathological Characteristics of Gastrointestinal Lymphoma: A Multicentric Study
Background: Extranodal non-Hodgkin lymphoma (NHL) is more prevalent in the gastrointestinal (GI) tract than in other sites. This study aimed to determine the endoscopic characteris...
The lymphedema patient experience within the healthcare system: a cross-sectional epidemiologic assessment
The lymphedema patient experience within the healthcare system: a cross-sectional epidemiologic assessment
AbstractLymphedema is a progressive lymphatic disease that potentiates physical and psychosocial distress. Despite its impact, patients reportedly encounter lymphatic ignorance thr...
The Kinetics of Lymphatic Dysfunction and Leukocyte Expansion in the Draining Lymph Node during LTB4 Antagonism in a Mouse Model of Lymphedema
The Kinetics of Lymphatic Dysfunction and Leukocyte Expansion in the Draining Lymph Node during LTB4 Antagonism in a Mouse Model of Lymphedema
The mechanisms of lymphedema development are not well understood, but emerging evidence highlights the crucial role the immune system plays in driving its progression. It is well k...

